These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa. Andrews JR, Shah NS, Gandhi N, Moll T, Friedland G, Tugela Ferry Care and Research (TF CARES) Collaboration. J Infect Dis; 2007 Dec 01; 196 Suppl 3():S482-90. PubMed ID: 18181698 [Abstract] [Full Text] [Related]
4. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa. Streicher EM, Müller B, Chihota V, Mlambo C, Tait M, Pillay M, Trollip A, Hoek KG, Sirgel FA, Gey van Pittius NC, van Helden PD, Victor TC, Warren RM. Infect Genet Evol; 2012 Jun 01; 12(4):686-94. PubMed ID: 21839855 [Abstract] [Full Text] [Related]
5. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend. Rajasekaran S, Chandrasekar C, Mahilmaran A, Kanakaraj K, Karthikeyan DS, Suriakumar J. J Indian Med Assoc; 2009 May 01; 107(5):281-2, 284-6. PubMed ID: 19886382 [Abstract] [Full Text] [Related]
12. Multidrug- and extensively drug-resistant tuberculosis in Africa and South America: epidemiology, diagnosis and management in adults and children. Schaaf HS, Moll AP, Dheda K. Clin Chest Med; 2009 Dec 08; 30(4):667-83, vii-viii. PubMed ID: 19925960 [Abstract] [Full Text] [Related]